Journalartikel

Jahr der Veröffentlichung: 2015

Seiten: 193-212

Zeitschrift: Ophthalmic Genetics

Bandnummer: 36

Heftnummer: 3

ISSN: 1381-6810

eISSN: 1744-5094

Open Access Status: Green

DOI Link: https://doi.org/10.3109/13816810.2013.863945

Verlag: Taylor and Francis Group

Abstract: 
This is to review the current state of knowledge on the functional and clinical aspects of bestrophin 1, a prominent member of a family of proteins involved in the control and properties of the light peak of the EOG. Initially human bestrophin 1 gene (BEST1) mutations were identified to underlie Best vitelliform macular dystrophy (VMD), a dominantly inherited, juvenile-onset form of macular degeneration. In the recent past the phenotypical spectrum of retinal disorders associated with BEST1 mutations has been extended and the term bestrophinopathies was coined. The physiological role of bestrophin 1 is still not completely understood but has been linked to the generation of a transepithelial chloride current by controlling voltage-dependent calcium channels (VDCC). Dysfunction of bestrophin 1 may result in abnormal ion and fluid transport by the retinal pigment epithelium (RPE) disturbing and even disrupting direct interactions between the RPE and the photoreceptors.

Harvard-Zitierstil: Pasquay, C., Wang, L., Lorenz, B. and Preising, M. (2015) Bestrophin I - Phenotypes and Functional Aspects in Bestrophinopathies, Ophthalmic Genetics, 36(3), pp. 193-212. https://doi.org/10.3109/13816810.2013.863945

APA-Zitierstil: Pasquay, C., Wang, L., Lorenz, B., & Preising, M. (2015). Bestrophin I - Phenotypes and Functional Aspects in Bestrophinopathies. Ophthalmic Genetics. 36(3), 193-212. https://doi.org/10.3109/13816810.2013.863945